Table 3.
References | Objective | Intervention | Number of subjects | Main outcome measures | Findings |
---|---|---|---|---|---|
Bierman et al. (2007) | To evaluate the effects of BZD use on cognitive function in the elderly. Data from the Longitudinal Aging Study Amsterdam (LASA), a population-based study |
9 year follow-up | 2,105 subjects aged 55 to 85 years. | General cognitive functioning measured by means of the Mini-mental State; Episodic memory measured with a Auditory Verbal Learning Test; Fluid intelligence measured by means of two sub-sets of 12 items (A and B) from Raven's Colored Progressive Matrices; Information processing speed measured by means of an adjusted version of the Coding task. |
The duration of treatment and cumulative exposure to BZD use had a negative effect on the cognitive function of elderly people. However, this effect was small. |
Boeuf-Cazou et al. (2011) | To investigate the impact of long-term BZD consumption on cognitive function Population from the VISAT study (Aging, Health and Work) (France). A prospective cohort study. |
10 year follow-up | 1,660 men and 1,577 women aged 32, 42, 52, and 62 years, classified according to the use of BDZs into non-users, occasional users and log-term users. | Cognitive function was assessed using five cognitive tests (immediate free recall test, delayed free recall test, recognition test, Digit Symbol Substitution Subtest and visual search speed test). | Long-term use of BDZs leads to specific impairment in long-term memory in women. |